| 000 | 01113 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250513094607.0 | ||
| 264 | 0 | _c19961001 | |
| 008 | 199610s 0 0 eng d | ||
| 022 | _a0927-3042 | ||
| 024 | 7 |
_a10.1007/978-1-4613-1239-0_13 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPetitjean, O | |
| 245 | 0 | 0 |
_aDrug interaction and pharmacological considerations during anti-infective therapy in cancer patients. _h[electronic resource] |
| 260 |
_bCancer treatment and research _c1995 |
||
| 300 |
_a255-80 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAlkalies |
| 650 | 0 | 4 |
_aAntacids _xtherapeutic use |
| 650 | 0 | 4 |
_aAnti-Infective Agents _xpharmacokinetics |
| 650 | 0 | 4 | _aCations |
| 650 | 0 | 4 | _aChelating Agents |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 | _aTissue Distribution |
| 700 | 1 | _aNicolas, P | |
| 700 | 1 | _aTod, M | |
| 773 | 0 |
_tCancer treatment and research _gvol. 79 _gp. 255-80 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/978-1-4613-1239-0_13 _zAvailable from publisher's website |
| 999 |
_c8743673 _d8743673 |
||